12:00 AM
 | 
Jun 22, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zyflo CR zileuton CR regulatory update

FDA requested that manufacturers of leukotriene modifying drugs for asthma update the labels of such drugs to include a precaution about behavior and mood changes that have been reported in patients taking the...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >